Antonio Sánchez-Cordero serves as Principal at ARCHIMED since March 2024, bringing extensive experience in business development and corporate strategy from previous roles, including Group Vice President of Strategy & Business Development (M&A) at Thermo Fisher Scientific and Worldwide Vice President of Business Development (M&A) at BD. With a strong foundation in strategy and marketing, Antonio has held senior positions at PDI, Ampersand Capital Partners, and Werfen, among others. Academic accomplishments include several executive programs at Harvard Business School and an MBA in Strategy & Marketing from Esade, as well as legal studies at Universitat Pompeu Fabra.